Hot Pursuit

Scrips, which has significant changes during the market hours.

DRL Hyderabad unit gets 3 observations from USFDA
09-Dec-23 11:16Hrs IST

The US drug regulator conducted good manufacturing practice (GMP) and pre-approval inspection at R&D centre in Bachupally, Hyderabad from 4 December 2023 to 8 December 2023.

Upon completion, the durg maker has been issued a Form 483 with three observations, which it will address within the stipulated timeline.

Dr. Reddy's Laboratories is engaged in providing medicines. The firm operates in three segments: global generics, pharmaceutical services and active ingredients (PSAI) and proprietary products.

The pharma company's consolidated net profit surged 33.0% YoY to Rs 1482.20 crore on 9.1% rise in net sales to Rs 6880.20 crore in Q2 FY24 over Q2 FY23.

Shares of Dr. Reddy's Laboratories shed 0.36% to end at Rs 5,763.50 on Friday, 8 December 2023.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise